HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of nitric oxide synthase with 7-nitroindazole does not modify early metabolic recovery following focal cerebral ischemia in rats.

Abstract
Nitric oxide has been strongly implicated in the development of tissue infarction in response to focal cerebral ischemia. Nitric oxide and its derivatives can inhibit components of the electron transport chain, providing a likely target for these substances in ischemic and post-ischemic brain. Lactate content is increased during post-ischemic reperfusion in tissue destined to become infarcted, consistent with impairment of mitochondrial respiration. To investigate the possible involvement of nitric oxide in generating these changes, we have tested the effect of 7-nitroindazole, a nitric oxide synthase (NOS) inhibitor, on the content of lactate and other metabolites during early reperfusion following temporary focal ischemia. This treatment inhibited total NOS by approximately 50%. However, the treatment did not significantly affect the marked increases in lactate in post-ischemic brain nor did it alter the recovery of other energy-related metabolites. These findings indicate that inhibition of oxidative metabolism is probably not the primary site of the deleterious effects of nitric oxide and derivatives during early post-ischemic reperfusion.
AuthorsStephen C Helps, Neil R Sims
JournalNeurochemical research (Neurochem Res) 2007 Apr-May Vol. 32 Issue 4-5 Pg. 663-70 ISSN: 0364-3190 [Print] United States
PMID17024570 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Indazoles
  • Phosphocreatine
  • Lactic Acid
  • Adenosine Diphosphate
  • Adenosine Triphosphate
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Glucose
  • 7-nitroindazole
Topics
  • Adenosine Diphosphate (metabolism)
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Energy Metabolism (drug effects, physiology)
  • Enzyme Inhibitors (pharmacology)
  • Glucose (metabolism)
  • Indazoles (pharmacology)
  • Infarction, Middle Cerebral Artery (pathology, prevention & control, surgery)
  • Ischemic Attack, Transient (metabolism)
  • Lactic Acid (metabolism)
  • Male
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Nitric Oxide Synthase Type I (antagonists & inhibitors)
  • Phosphocreatine (metabolism)
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: